MPX Bioceutical Corporation (OTC:MPXEF) is a universal cannabis company concentrated on the medical and recreational use of marijuana. The company has branded itself to establish a growing presence in the U.S with immediate plans to open ten dispensaries and four production facilities in four states. MPX also filed a license application to Health Canada to operate and grow cannabis on Canadian soil.
Melting Point Extracts (MPX) has been establishing a credible brand for the past couple years with a huge boost from the company’s foundation which is its extremely profitable operations in Arizona. The company currently owns and operates three fully functional Health for Life dispensaries and The Holistic Center (recently purchased in the first quarter of 2018), which gives MPX a total of four operating dispensaries in the state of Arizona.
In Nevada, MPX (OTC:MPXEF) currently operates GreenMart which is a fully licensed cultivation, production and wholesale cannabis business. Construction is under way for the first of three dispensaries in Massachusetts as Medical Marijuana just become legal in the state.
What makes this company attractive is the high-hopes of a good earnings report that is supposed to occur at the end of trading on Monday August 31st. This report could determine the future for not only this company but the entire U.S cannabis market.
MPX Bioceutical (OTC:MPXEF) is one of many U.S marijuana companies that actually posts profits for at least one of their cannabis facilities. If earnings goes well, this stock could soar past the $1 as hype will continue to grow for this industry.
MPX (OTC:MPXEF) is currently being traded at $0.66 a share and has an all-time high of $0.935. This company is currently on our Watchlist and will be updated after-hours when we find out how the earnings report goes.